Nurix Therapeutics Inc Annual Shareholders Meeting Transcript
Good morning.
This is Arthur Sands, President and Chief Executive Officer of Nurix Therapeutics. I'd like to welcome you to Nurix's 2026 Annual Meeting of Stockholders. It's 9 a.m. Pacific Time on May 15, 2026, and this meeting is officially called to order.
This is our agenda for today's meeting. First, I will introduce our independent auditors and our inspector of elections, and then I will review the legal requirements for conducting business at this meeting.
I will then open the polls for voting and introduce the items of business at this meeting, which are listed briefly here as Agenda Item 3.
During voting, I will give a short presentation on Nurix's key achievements and progress over the past year. I will then close the polls and provide preliminary voting results.
Finally, we will conclude with a brief Q&A session.
Stockholders may submit a question by typing it in the Ask a Question section at the bottom of your screen.
We will
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
